Because typhoid fever continues to be a major cause of illness in many developing countries, there is a clear need for a sensitive and specific test that will permit rapid laboratory diagnosis of the disease. An enzyme-linked immunosorbent assay (ELISA) has recently been developed and tested, both in the laboratory and in a clinical situation, for its ability to detect Vi antigen in urine. The ELISA was capable of detecting as little as 1 ng of purified Vi antigen per ml in urine, compared with 100 ng/ml detectable by a previously tested coagglutination method. It could also detect antigen in urine diluted as much as 1:1,024 in normal urine. In tests of urine specimens from six stool culture-positive persons in a small typhoid outbreak in the United States, the ELISA detected antigen in specimens from four of the six patients. The ELISA also proved to be specific, giving no false-positive results for specimens from 50 persons who did not have typhoid fever. The apparent high sensitivity and specificity of this ELISA make it a promising test for rapid diagnosis of typhoid fever.
Despite its diminishing incidence in the United States and Europe, typhoid fever remains a major cause of illness in many parts of the developing world. The diagnosis of typhoid fever in these areas is frequently made solely on clinical grounds. Blood and stool cultures are done in relatively few hospitals, and many cultures are falsely negative due to prior antibiotic treatment. Even when appropriate cultures are taken, presumptive bacteriological results require 1 or 2 days, and confirmation requires even longer.
Serological diagnosis of typhoid fever (the Widal test) has been found by some investigators to be unreliable (3, 8) . In areas with endemic typhoid, serodiagnosis requires both acute and convalescent sera, since the prevalence of 0 and H antibodies in the adult and adolescent populations is high (3) One of the two infected persons who did not have Vi antigen detected in urine had the longest interval between onset of symptoms and the collection of urine (35 days). The other Vi antigen-negative person had not been ill and had low 0 and H antibody titers, indicating a probable chronic carrier state in which circulating antigens would not usually be expected. The only person whose urine was positive by both tests for Vi antigen was the only person who was known to have a culture-positive stool at the time the urine samples were collected.
DISCUSSION
The sensitivity of the ELISA in detecting Vi antigen (1 ng/ml) is comparable to the reported sensitivites of ELISAs for other bacterial antigens in body fluids (7) . The sensitivity we observed for the coagglutination test (100 ng/ml) is also similar to the sensitivity of the coagglutination test for Escherichia coli heat-labile enterotoxin reported by Brill et al. (1) . The 100-fold greater sensitivity of the ELISA proved valuable in testing clinical specimens, since four of six urine samples were positive by the ELISA, whereas only one of six was positive by coagglutination.
Since 0 of 10 urine specimens from non-ill exposed persons and 0 of 40 urine specimens from persons who were not exposed to S. typhi gave positive results, the specificity of the test appears to be excellent. Two (4%) of these urine specimens had nonspecific reactions that made the tests impossible to interpret. The reason for these nonspecific reactions was not identified.
Our clinical samples were unusual, since all were collected at least 1 month after onset of illness ( Table 1 ). The lateness of collection almost certainly reduced the chance of finding Vi antigen in the urine to below the chance of finding it in a hospital setting, where specimens would normally be obtained from acutely ill persons 5 to 7 days after onset. Since the coagglutination test is less sensitive than the ELISA, delay in specimen collection may have affected the coagglutination test results more than the ELISA results. Only one person was known to be still excreting S. typhi at the time of urine and serum collection, and his urine was positive by the coagglutination test as well as by the ELISA. This person also had the highest level of Vi antibodies in serum of the six tested.
The number of persons who would have been diagnosed as having had typhoid fever on the basis of Vi antigen in urine (four of six) was similar to the number who would have been diagnosed by elevated levels of Vi (four of six), O (four of six), or H (four of six) antibodies. The similarity of these test results may not be observed in areas with endemic typhoid, where the prevalence of 0 and H antibodies is high in the normal population (3) .
The apparent high sensitivity and specificity of the ELISA for Vi antigen in urine make it a promising test for the rapid diagnosis of typhoid fever. An evaluation of its usefulness in an area with endemic typhoid is being planned. Simultaneous evaluation of the coagglutination test is also planned, since the greater sensitivity and specificity of the more cumbersome ELISA may not prove to be as advantageous in a hospital setting as our current data imply.
